Jane Street Group, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 136,390 shares of ARCT stock, worth $991,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,390

Previous 32,100 324.89%

Holding current value

$991,555

Previous $417,000 502.64%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$11.39 - $22.17 $1.55 Million - $3.02 Million	136,390 New	136,390 $2.51 Million
Q1 2025 May 14, 2025	SELL	$10.59 - $20.83 $74,458 - $146,455	-7,031 Reduced 7.33%	88,921 $941,000
Q4 2024 Feb 14, 2025	BUY	$14.82 - $25.48 $535,743 - $921,102	36,150 Added 60.45%	95,952 $1.63 Million
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $240,644 - $337,807	-13,310 Reduced 18.2%	59,802 $1.39 Million
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $615,933 - $1.12 Million	25,295 Added 52.9%	73,112 $1.78 Million

Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $735,122 - $1.01 Million	-23,539 Reduced 32.99%	47,817 $1.61 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $134,737 - $250,835	-7,608 Reduced 9.63%	71,356 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $710,895 - $1.04 Million	27,944 Added 54.77%	78,964 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $40,745 - $55,076	1,702 Added 3.45%	51,020 $1.46 Million
Q1 2023 May 15, 2023	SELL	$14.72 - $23.97 $530,273 - $863,495	-36,024 Reduced 42.21%	49,318 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $767,660 - $1.25 Million	54,290 Added 174.84%	85,342 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $76,681 - $130,035	-5,876 Reduced 15.91%	31,052 $461,000
Q2 2022 Aug 16, 2022	BUY	$12.26 - $31.17 $288,342 - $733,087	23,519 Added 175.4%	36,928 $581,000
Q1 2022 May 17, 2022	SELL	$17.64 - $39.57 $496,460 - $1.11 Million	-28,144 Reduced 67.73%	13,409 $362,000
Q4 2021 Feb 15, 2022	SELL	$34.2 - $47.56 $470,079 - $653,712	-13,745 Reduced 24.86%	41,553 $1.54 Million
Q3 2021 Nov 16, 2021	BUY	$27.88 - $58.25 $829,374 - $1.73 Million	29,748 Added 116.43%	55,298 $2.64 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $1.58 Million - $2.58 Million	-61,276 Reduced 70.57%	25,550 $865,000
Q4 2020 Feb 17, 2021	SELL	$34.61 - $123.66 $2.31 Million - $8.25 Million	-66,730 Reduced 43.46%	86,826 $3.77 Million
Q3 2020 Nov 17, 2020	BUY	$37.49 - $63.19 $2.45 Million - $4.14 Million	65,468 Added 74.32%	153,556 $6.59 Million
Q2 2020 Aug 17, 2020	BUY	$12.66 - $58.27 $883,174 - $4.06 Million	69,761 Added 380.65%	88,088 $4.12 Million
Q1 2020 May 15, 2020	BUY	$9.31 - $18.26 $170,624 - $334,651	18,327 New	18,327 $249,000

Others Institutions Holding ARCT

# of Institutions

173

Shares Held

26M

Call Options Held

2.32M

Put Options Held

866K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $193M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Arcturus Therapeutics Holdings Inc. Transaction History